R. Rawat et al., Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas, BLOOD, 96(10), 2000, pp. 3514-3521
Interleukin 6 (IL-6), the major growth factor for myeloma cells, signals th
rough the activation of signal transducers and activators of transcription
(STAT) proteins. An important step in the malignant progression of murine p
lasmacytomas is the transition from dependence on IL-6 to a state of IL-6 i
ndependence. To elucidate the mechanism whereby IL-6 independence occurs, i
ntracellular signaling events elicited by IL-6 in both IL-6-dependent and -
independent plasmacytomas and hybridomas were compared. It was found that S
TAT3, a key molecule involved in IL-6 signaling, was constitutively activat
ed and phosphorylated in IL-6-independent cell lines compared to the IL-6-d
ependent cells. Further comparison of up stream signaling pathways revealed
that JAK-1 was constitutively present in antiphosphotyrosine immunoprecipi
tates of IL-6-independent cells; gp180 was constitutively phosphorylated in
a subset of IL-6 independent plasmacytomas, whereas other IL-6-independent
lines showed no detectable gp130 phosphorylation in the absence of exogeno
us IL-6, Secretion of a factor capable of supporting the growth of IL-6-dep
endent cells was observed in one of the IL-6-independent plasmacytomas, but
not in others, making an autocrine mechanism an unlikely explanation for I
L-6 independence. These findings provide evidence that the constitutive act
ivation of STAT3, either in the absence of detectable receptor-proximal eve
nts or associated with the concomitant activation of gp130, can contribute
to the process of IL-6 independence. (C) 2000 by The American Society of He
matology.